Page 15 - ANZCP Gazette November 2021

Gazette for ANZ perfusionists_ADVERTORIAL_FINAL.indd 1 06/08/2021 01:18 NOVEMBER 2021 | www.anzcp.org 12
Quantra delivers
‘sniper attack’ to deal
with critical bleeding
“Without viscoelastic testing, I would have treated this patient with shotgun therapy...now I use the Quantra
for sniper attacks on hypocoagulability”, cardiac surgeon Dr Pierre R. Tibi on open heart surgery protocols at Yavapai Regional Medical Centre, Arizona, US
Acute perioperative situations demand fast action on whether to transfuse critically bleeding patients. Patient blood management must therefore
be a multi-disciplinary effort aimed at improving patient outcomes.
With a fully enclosed cartridge, Quantra needs no manual pipetting
In less than 15 minutes, the Quantra haemostasis analyser and QPlus cartridge provide critical information about clotting time and the quality of any formed clot. You can read the results the moment they appear on the screen, without needing to decipher complex curves. Data can also be shared remotely with the blood bank, clinical colleagues or laboratory via the Quantra Desktop Remote Viewer.
Quantra is the first viscoelastic testing device to provide direct quantification of the Platelet Contribution to Clot Stiffness (PCS), measuring clot elasticity, rather
than amplitude. This accounts for both platelet count and platelets’ ability to aggregate, contract, and contribute to clot strengthening. The Quantra can measure the evolving clot stiffness without any manipulation or disruption to the clot.
Comprehensive diagnostic panel
The QPlus cartridge provides a comprehensive diagnostic panel with six parameters - clot times with and without heparinase (CT and CTH), clot stiffness (CS) and fibrinogen contribution to clot stiffness (FCS). Two unique parameters are then automatically calculated: clot time ratio (CTR), and platelet contribution to clot stiffness (PCS). Unlike some other systems, clot stiffness parameters can be
used while patients are on bypass. The QStat cartridge provides an additional parameter, the Clot Stability to Lysis (CSL), a quantitative analysis of fibrinolysis.
Clinical studies indicate high precision, generally strong correlation with standard laboratory assays, good concordance with the clinical presentation and high negative predictive value for thrombocytopenia.
A recent study identified potential cut-off values for the FCS and PCS parameters for use in place of, or alongside, lab-based fibrinogen and platelet thresholds to guide transfusion decisions.
Pioneering use of ultrasound
For the first time in viscoelastic testing, Quantra uses ultrasound technology to measure the dynamic changes as a clot
Easy-to-interpret, intuitive dials display
forms. Unlike classic systems, the Quantra cartridge is fully enclosed, with no need for pipetting. This minimises the risk of blood exposure.
Also, there are no moving parts to come into contact with the blood and potentially disrupt clot formation, increasing sensitivity to early clot formation and
to the soft clots often linked to bleeding.
Patient Blood Management programs integrate viscoelastic testing to enable better clinical decision-making, cost savings and optimal patient care. Data from the Quantra has enabled the development of more simplified treatment algorithms to apply targeted therapy in the management of bleeding patients.
New Quantra POC Solution website
Visit www.quantrapocsolution.com, the new website dedicated exclusively to Quantra. Find out exactly what singles out this innovative, viscoelastic testing system - from results’ delivery within 15 minutes to the expanding bibliography of Quantra-related clinical studies.
For more information or to request
a demo, email info@au.stago.com or call 1800 4 Stago (1800 4 78246) for Australia or 0508 4 Stago (0508 4 78246) for New Zealand.
Diagnostica Stago, a global leader in haemostasis and thrombosis, expanded into point-of-care with the acquisition of HemoSonics.
References on request
Diagnostica Stago Pty Ltd · 351 Burwood Highway · Forest Hill, Victoria 3131 · Australia. Tel: 1800 4 78246